StonvexLoading…
StonvexStonvexStonvexCore line items from NEPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $18.79M | $14.16M | $14.24M | $9.97M |
Operating Income | $1.15M | $6.00K | $-1.59M | $-4.33M |
Net Income | $1.19M | $74.00K | $-1.57M | $-7.11M |
EPS (Diluted) | $0.11 | $0.01 | $-0.15 | $-0.73 |
Total Assets | $13.64M | $11.21M | $11.86M | $11.00M |
Total Liabilities | $3.44M | $2.63M | $3.50M | $2.12M |
Cash & Equivalents | $5.40M | $3.76M | $4.31M | $3.63M |
Free Cash Flow OCF − CapEx | Not available | $-547.00K | $752.00K | $-3.37M |
Shares Outstanding | 10.64M | 10.54M | 10.54M | 10.30M |